CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...
Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, ...
This educational article was made possible with materials and support from Tandem Diabetes Care. Automated insulin delivery (AID) systems have been traditionally used by people with type 1 diabetes ...
Because GLP-1 receptor agonists slow down digestion, they may delay the absorption of oral medications like birth control pills, which could affect ovulation and fertility. As more people begin taking ...
Many important molecules in the body are peptides. Some peptides, like GLP-1, can be modified into effective medications for a variety of conditions, including diabetes. Recently, health, wellness, ...
Many people with diabetes struggle to manage mealtime blood sugar levels, even with new advances in technology. In a clinical trial of adults with type 1 diabetes, the inhaled insulin Afrezza ...
Keeping blood sugars in balance is crucial for people with diabetes. Fenugreek, apple cider vinegar, and supplements like fiber and zinc are all-natural treatments that may help lower glucose levels.
Recent integrations between continuous glucose monitors and insulin pumps are allowing diabetes tech users to choose between more options. Tandem t:slim X2 users can now use either the FreeStyle Libre ...
As people with diabetes age, the glucose management strategies they’ve relied on for decades may need some adjustment. Researchers at ATTD 2025 presented various strategies for simplifying treatment ...
The American Diabetes Association recently released major diabetes care updates, which include new recommendations on diabetes technology, therapy, and preventative health. The ADA's annual Standards ...
While an A1C blood test has long been the standard for assessing blood sugar management, it can often be inaccurate in people with diabetes. GMI is a metric that uses CGM data to estimate your A1C.
Diabetes stigma includes the experiences of exclusion, rejection, prejudice, and blame that some people with diabetes encounter. Learn how to identify this stigma, how it can lead to worse health ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results